1st Quarter - Amendment

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$490,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2010 $475,000 Replaced
1st Quarter - Amendment (this page) Nov 25, 2011 $490,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

HEU/LEU related issues for nuclear medicine; H.R. 3276 - American Medical Isotopes Production Act of 2009 (all provisions).

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: Commerce, Dept of (DOC); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 3276 (111th)

Financial Institutions/Investments/Securities FIN

Financial Regulatory - issues relating to derivatives; H.R. 4173 - Wall Street Return and Consumer Protection Act (all provisions); "Restoring American Financial Stability Act."

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: SENATE; Commerce, Dept of (DOC); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 4173 (111th)

Pharmacy PHA

Issues related to controlled substances, pain and addiction drugs generally.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Copyright/Patent/Trademark CPT

S. 515/H.R. 1260 - Patent Reform Act of 2009 (all provisions).

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: White House Office; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA)

Bills named: H.R. 1260 (111th), S. 515 (111th)

Taxation/Internal Revenue Code TAX

S. 506 - Stop Tax Haven Abuse Act (all provisions); H.R. 1265 - Stop Tax Haven Abuse Act (all provisions); H.R. 4849 - Small Business and Infrastructure Jobs Tax Act of 2010 (all provisions); International tax on foreign direct investment generally.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
TIMOTHY MCBRIDE for Management and Administration

Contacted: Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 506 (111th), H.R. 1265 (111th), H.R. 4849 (111th)

Health Issues HCR

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act (all provisions); H.R. 2502 - Comparative Effective Research Act of 2009 (all provisions); S. 1142 - Informed Health Care Decision Making Act (all provisions). S. 1679 - Affordable Health Choice Act (all provisions); H.R. 3590 - Patient Protection and Affordable Care Act of 2009 (all provisions); H.R. 3962 - Affordable Healthcare for American Act (all provisions); S. 1796 - "The Americas Healthy Future Act of 2009" (all provisions); Issues relating to the medical device tax/fee; Senate Finance Committee Healthcare Reform Bill; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 (all provisions).

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE for Management and Administration

Contacted: SENATE; Commerce, Dept of (DOC); White House Office; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4872 (111th), S. 1679 (111th), H.R. 3590 (111th), S. 1796 (111th), S. 1142 (111th), H.R. 2502 (111th), S. 1213 (111th), H.R. 3962 (111th)

Budget/Appropriations BUD

Administration FY 2011 Budget

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
TIMOTHY MCBRIDE for Management and Administration

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Medicare/Medicaid MMM

Issues related to comparative effectiveness; S.301 - Physician Payments Sunshine Act of 2009 (all provisions).

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —

Contacted: Food & Drug Administration (FDA); White House Office; Office of Science & Technology Policy (OSTP); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 301 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.